Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy
甲胎蛋白和去γ-羧基凝血酶原可以预测接受度伐利尤单抗联合曲美利尤单抗治疗的肝细胞癌患者的客观疗效。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0311084
Saeki, Issei; Shimose, Shigeo; Tomonari, Tetsu; Ito, Takanori; Tani, Joji; Takeuchi, Yasuto; Yoshioka, Naoki; Naito, Takehito; Takeuchi, Mamiko; Kakizaki, Satoru; Hatanaka, Takeshi; Sasaki, Kyo; Yasunaka, Tetsuya; Sakata, Masahiro; Iwamoto, Hideki; Itano, Satoshi; Shirono, Tomotake; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Otsuka, Motoyuki; Kobara, Hideki; Kawashima, Hiroki; Takayama, Tetsuji; Kawaguchi, Takumi; Yamasaki, Takahiro; Takami, Taro